GFI Extends MDD Certificate for GERD Devices

Extension of MDD Certificate for Our Medical Devices for the Treatment of Gastroesophageal Reflux Disease (GERD) Based on Alginates The MDR regulation, effective from May 2017 and applicable from May 2021, governs medical devices in Europe. Deadline extensions allow the marketing of devices compliant with the Medical Devices Directive (MDD) until December 31, 2027, for…

GFI Registers Oral Emulsion for GERD in Vietnam

Gruppo FarmaImpresa completes the registration process for an oral emulsion for Gastroesophageal Reflux Disease Treatment With pride, we present our recent success in obtaining registration for a Class IIa medical device in Vietnam. This device, based on low molecular weight hyaluronic acid, sodium alginate, myrrh extract, and simethicone, is indicated for the treatment of gastroesophageal…